Dec. 7 at 1:10 AM
$HRTX I’ve had a disappointing experience in the last few weeks.
I was recently scheduled for a knee replacement surgery on December 9. I asked my orthopedic surgeon to use Zynrelef as my post surgery pain killer versus opioids. He was familiar with it, but said the drug wasn’t approved by the hospital. I suggested getting it approved, but he said it was too late for my surgery because multiple committees had to sign off on it.
I live in Madison, Wisconsin, home of the Badgers and several well respected healthcare facilities. So I asked my doctor if Zynrelef is approved in any of the Madison area hospitals. He said none that he knows of.
Disappointing, and a good example of inadequate sales coverage and marketing. Like many of you, I’ve been an investor in Heron for several years. Sales of Zyn is the key, and they obviously need a more dedicated sales force. Perhaps it means selling Zenrelef to a larger company that has an adequate sales force.
